BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10864915)

  • 21. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.
    Bono P; Salmi M; Smith DJ; Jalkanen S
    J Immunol; 1998 Jun; 160(11):5563-71. PubMed ID: 9605161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syn-capping of human T lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells.
    Rosenman SJ; Ganji AA; Tedder TF; Gallatin WM
    J Leukoc Biol; 1993 Jan; 53(1):1-10. PubMed ID: 7678845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction and function of vascular adhesion protein-1 at sites of inflammation.
    Salmi M; Kalimo K; Jalkanen S
    J Exp Med; 1993 Dec; 178(6):2255-60. PubMed ID: 8245796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion.
    Lalor PF; Sun PJ; Weston CJ; Martin-Santos A; Wakelam MJ; Adams DH
    Hepatology; 2007 Feb; 45(2):465-74. PubMed ID: 17256751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible stimulation of lymphocyte motility by cultured high endothelial cells: mediation by L-selectin.
    Harris H; Miyasaka M
    Immunology; 1995 Jan; 84(1):47-54. PubMed ID: 7534263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off.
    Greenwood J; Wang Y; Calder VL
    Immunology; 1995 Nov; 86(3):408-15. PubMed ID: 8550078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans.
    Salmi M; Jalkanen S
    Science; 1992 Sep; 257(5075):1407-9. PubMed ID: 1529341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate.
    Kivi E; Elima K; Aalto K; Nymalm Y; Auvinen K; Koivunen E; Otto DM; Crocker PR; Salminen TA; Salmi M; Jalkanen S
    Blood; 2009 Dec; 114(26):5385-92. PubMed ID: 19861682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models.
    Salmi M; Jalkanen S
    Eur J Immunol; 1995 Oct; 25(10):2803-12. PubMed ID: 7589075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans.
    Salmi M; Jalkanen S
    Blood; 2006 Sep; 108(5):1555-61. PubMed ID: 16556889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte-endothelial interactions in inflamed synovia: involvement of several adhesion molecules and integrin epitopes.
    Fischer C; Thiele HG; Hamann A
    Scand J Immunol; 1993 Aug; 38(2):158-66. PubMed ID: 7688480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LFA-1 and L-selectin regulation of recirculating lymphocyte tethering and rolling on lung microvascular endothelium.
    Li X; Abdi K; Rawn J; Mackay CR; Mentzer SJ
    Am J Respir Cell Mol Biol; 1996 Apr; 14(4):398-406. PubMed ID: 8600945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin.
    Aho R; Kalimo H; Salmi M; Smith D; Jalkanen S
    J Neuropathol Exp Neurol; 1997 May; 56(5):557-68. PubMed ID: 9143269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
    Sun P; Solé M; Unzeta M
    Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T lymphocyte adhesion to endothelial cells and transendothelial migration. Alteration of receptor use relates to the activation status of both the T cell and the endothelial cell.
    Oppenheimer-Marks N; Davis LS; Lipsky PE
    J Immunol; 1990 Jul; 145(1):140-8. PubMed ID: 1972715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
    Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
    Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells.
    Carlos TM; Schwartz BR; Kovach NL; Yee E; Rosa M; Osborn L; Chi-Rosso G; Newman B; Lobb R
    Blood; 1990 Sep; 76(5):965-70. PubMed ID: 1697486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion.
    Spertini O; Luscinskas FW; Kansas GS; Munro JM; Griffin JD; Gimbrone MA; Tedder TF
    J Immunol; 1991 Oct; 147(8):2565-73. PubMed ID: 1717567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium.
    Irjala H; Salmi M; Alanen K; Grénman R; Jalkanen S
    J Immunol; 2001 Jun; 166(11):6937-43. PubMed ID: 11359855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human vascular adhesion protein-1 in smooth muscle cells.
    Jaakkola K; Kaunismäki K; Tohka S; Yegutkin G; Vänttinen E; Havia T; Pelliniemi LJ; Virolainen M; Jalkanen S; Salmi M
    Am J Pathol; 1999 Dec; 155(6):1953-65. PubMed ID: 10595925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.